|
Daily Medical Update
Peripartum cardiomyopathy
Thursday, May 21, 2026
|
🔬 Practice-Changing Findings
Evidence from RCTs and meta-analyses published in the
last 12 months.
|
ESC heart failure (2025) - Meta-Analysis
Key Findings
- Bromocriptine plus standard care improved left ventricular ejection fraction by 9.98 percentage points versus standard care alone.
- Left ventricular end-diastolic and end-systolic dimensions were reduced by 2.51 cm and 5.61 cm, respectively, with bromocriptine.
- Major adverse cardiovascular events, all-cause mortality, and heart failure rehospitalization did not differ significantly between groups.
📋 Practice Implication: Consider bromocriptine as an adjunct for patients with newly diagnosed PPCM who need faster ventricular recovery, while recognizing that survival benefit remains unproven.
|
The American journal of cardiology (2025) - Multicenter Study
Key Findings
- At 180 days, all-cause mortality in PPCM with cardiogenic shock was 15.8%.
- Durable LVAD implantation occurred in 15.0% of the cohort and heart transplantation in 12.9%.
- Mortality was 24.1% with ECMO support and 18.7% with IABP or pLVAD support, reflecting the severity of patients needing advanced support.
📋 Practice Implication: Treat PPCM with cardiogenic shock as an advanced heart failure emergency and involve mechanical support and transplant-capable teams early.
|
JACC. Advances (2026) - Journal Article
Key Findings
- Mean left ventricular ejection fraction at presentation was lower in Black women than White women (26% vs 29%).
- Recovery of ejection fraction was less frequent in Black women than White women (40% vs 63%).
- Mortality was higher in Black women than White women (8% vs 2%).
📋 Practice Implication: Follow-up intensity and access-to-care interventions should be deliberately strengthened for Black patients, because worse recovery and mortality were not explained by large differences in measured risk factors.
|
Open heart (2025) - Meta-Analysis
Key Findings
- Right ventricular dysfunction was present in 48% of patients with PPCM.
- Right ventricular dysfunction was associated with more composite adverse outcomes, including death, LVAD, transplant, or ECMO use, with a hazard ratio of 2.71.
- Patients with right ventricular dysfunction had a higher risk ratio for unrecovered left ventricular function of 1.62.
📋 Practice Implication: Initial echocardiography in PPCM should explicitly document right ventricular function, because its presence identifies a higher-risk phenotype that merits closer surveillance and escalation planning.
|
Acta obstetricia et gynecologica Scandinavica (2025) - Meta-Analysis
Key Findings
- Relapse of cardiac failure in the first subsequent pregnancy occurred in 32% of women overall.
- Relapse risk was 24% in women with recovered cardiac function and 36% in those without recovered function at conception.
- Preterm birth before 37 weeks occurred in 22% of subsequent pregnancies.
📋 Practice Implication: Preconception counseling after PPCM should remain conservative even after ejection fraction recovery, with shared decision-making that includes relapse and preterm birth risk.
|
|
💡
Summary
Recent peripartum cardiomyopathy evidence emphasizes early risk stratification and escalation: right ventricular dysfunction, cardiogenic shock, and racial inequities identify patients with markedly worse recovery and mortality, while bromocriptine added to standard therapy improves left ventricular remodeling without a proven mortality benefit. Counseling after apparent recovery remains important because subsequent pregnancy still carries substantial relapse and preterm birth risk.
|
|